thiophenes has been researched along with tibolone in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (60.00) | 29.6817 |
2010's | 3 (30.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Galid, A; Kubista, E; Seifert, M | 1 |
Biskobing, DM; Downs, R; Novy, AM | 1 |
Parfitt, AM; Riggs, BL | 1 |
Christiansen, C; Gambacciani, M; Genazzani, AR; Schneider, HP | 1 |
Bors, K | 1 |
Doggrell, SA | 1 |
Arun, B; Brown, PH; Castiglione, M; Cuzick, J; DeCensi, A; Dunn, B; Forbes, JF; Glaus, A; Howell, A; Vogel, V; von Minckwitz, G; Zwierzina, H | 1 |
Stevenson, JC | 1 |
Briarava, M; Mocellin, S; Nitti, D; Pilati, P | 1 |
Elgebaly, Z; Elliott, J; Naik-Panvelkar, P; Norman, S; Pollack, A; Seibel, MJ; Thistlethwaite, J; Weston, C | 1 |
7 review(s) available for thiophenes and tibolone
Article | Year |
---|---|
Novel therapeutic options for osteoporosis.
Topics: Animals; Controlled Clinical Trials as Topic; Diphosphonates; Disease Models, Animal; Evidence-Based Medicine; Fractures, Spontaneous; Glycoproteins; Humans; Ibandronic Acid; Imidazoles; Norpregnenes; Osteoporosis; Osteoprotegerin; Piperidines; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Selective Estrogen Receptor Modulators; Thiophenes; Zoledronic Acid | 2002 |
Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling.
Topics: Adult; Age Factors; Aged; Aging; Anabolic Agents; Bone and Bones; Bone Density; Bone Development; Bone Remodeling; Bone Resorption; Female; Humans; Middle Aged; Models, Biological; Norpregnenes; Organometallic Compounds; Osteoblasts; Osteoporosis; Osteoporosis, Postmenopausal; Teriparatide; Terminology as Topic; Testosterone; Thiophenes; Time Factors | 2005 |
[Up-to-date treatments for osteoporosis].
Topics: Bone Density; Bone Density Conservation Agents; Bone Regeneration; Calcitonin; Calcium Compounds; Diphosphonates; Drugs, Investigational; Estrogen Replacement Therapy; Fluorides; Fractures, Bone; Humans; Norpregnenes; Organometallic Compounds; Osteoporosis; Osteoporosis, Postmenopausal; Selective Estrogen Receptor Modulators; Teriparatide; Testosterone; Thiophenes; Vitamin D | 2006 |
New findings with old drugs for osteoporosis.
Topics: Bone Density Conservation Agents; Clinical Trials as Topic; Diphosphonates; Female; Humans; Norpregnenes; Organometallic Compounds; Osteoporosis, Postmenopausal; Stroke; Thiophenes | 2009 |
Preventive therapy for breast cancer: a consensus statement.
Topics: Anastrozole; Androstadienes; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Consensus Development Conferences as Topic; Diphosphonates; Estrogen Receptor Modulators; Expert Testimony; Female; Fenretinide; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Metformin; Nitriles; Norpregnenes; Piperidines; Premenopause; Pyrrolidines; Raloxifene Hydrochloride; Retinoids; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Thiophenes; Triazoles | 2011 |
Prevention of osteoporosis: one step forward, two steps back.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Calcitonin; Calcium; Denosumab; Diphosphonates; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Norpregnenes; Organometallic Compounds; Osteoporosis, Postmenopausal; Practice Guidelines as Topic; Teriparatide; Thiophenes; Vitamin D | 2011 |
Breast Cancer Chemoprevention: A Network Meta-Analysis of Randomized Controlled Trials.
Topics: Adult; Aged; Anticarcinogenic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Middle Aged; Norpregnenes; Piperidines; Postmenopause; Primary Prevention; Pyrrolidines; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk Assessment; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Thiophenes | 2016 |
3 other study(ies) available for thiophenes and tibolone
Article | Year |
---|---|
The oestrogen receptor and its selective modulators in gynaecological oncology.
Topics: Antineoplastic Agents, Hormonal; Cinnamates; Estrogen Antagonists; Female; Genital Neoplasms, Female; Humans; Norpregnenes; Piperidines; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Stilbenes; Tamoxifen; Thiophenes; Toremifene | 2000 |
Postmenopausal osteoporosis: therapeutic options.
Topics: Age Factors; Anabolic Agents; Animals; Bone Density; Calcium; Contraceptives, Oral; Diphosphonates; Disease Models, Animal; Estrogen Replacement Therapy; Female; Fractures, Bone; Humans; Norpregnenes; Organometallic Compounds; Osteoporosis, Postmenopausal; Risk Factors; Selective Estrogen Receptor Modulators; Spinal Fractures; Thiophenes; Vitamin D | 2005 |
Osteoporosis management in Australian general practice: an analysis of current osteoporosis treatment patterns and gaps in practice.
Topics: Aged; Aged, 80 and over; Attitude of Health Personnel; Australia; Bone Density Conservation Agents; Denosumab; Deprescriptions; Diphosphonates; Drug Substitution; Female; General Practice; General Practitioners; Humans; Longitudinal Studies; Male; Middle Aged; Norpregnenes; Osteoporosis; Osteoporotic Fractures; Practice Patterns, Physicians'; Raloxifene Hydrochloride; Retrospective Studies; Teriparatide; Thiophenes | 2020 |